Barriers to compliance with prophylaxis therapy in haemophilia

被引:234
|
作者
Hacker, MR [1 ]
Geraghty, S [1 ]
Manco-Johnson, M [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO 80045 USA
关键词
children; compliance; haemophilia; prophylaxis;
D O I
10.1046/j.1365-2516.2001.00534.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prophylaxis, or the practice of routine replacement infusions of clotting factor concentrate in persons with severe haemophilia, is a demanding medical regimen. Prophylactic infusions require direct venepuncture or sterile entry into a central venous access device on a regular basis. A telephone survey was conducted to elicit information regarding the barriers to compliance with prophylaxis. The Mountain States Regional Haemophilia and Thrombosis Center has recommended prophylaxis to 52 male patients with haemophilia A or B. The haemophilia nurse attempted to contact all of these patients or their parents, and contact was made with 38 (73.1%) of them. Respondents were asked about the following issues: their decision to initiate prophylaxis; their self-rated compliance; the challenges, barriers, and facilitators of prophylaxis; and their perceived value of the therapy. Four patients (10.5%) elected not to begin prophylaxis. Of the 34 persons who began prophylaxis, 20 respondents (58.8%) rated their compliance as excellent. Nearly one-third of the families with excellent compliance (giving 75-100% of prescribed infusions) stated that the time-consuming nature of prophylaxis was the most significant challenge of the regimen. In addition, 58.3% of the families that gave less than the prescribed number of infusions reported that the time commitment was the primary reason for missing infusions. Knowledge of the benefits of prophylaxis was the primary facilitator of compliance for 44.1% of families. Ninety-seven percent of respondents rated prophylaxis as very valuable. These data show that despite the known benefits of prophylaxis, it is a demanding medical regimen, and compliance is imperfect. In addition, this study underscores the importance of providing continuing support and education for patients and families who are implementing prophylaxis.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 50 条
  • [1] Identifying and overcoming barriers to prophylaxis in the management of haemophilia
    Petrini, P.
    HAEMOPHILIA, 2007, 13 : 16 - 22
  • [2] Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan
    Taki, M.
    Shirahata, A.
    HAEMOPHILIA, 2009, 15 (01) : 78 - 82
  • [3] Prophylaxis in people with haemophilia
    Coppola, Antonio
    Franchini, Massimo
    Tagliaferri, Annarita
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 674 - 681
  • [4] Prophylaxis therapy in haemophilia A: current situation in Spain
    Lucia, J. F.
    Aznar, J. A.
    Abad-Franch, L.
    Escuin, R. R.
    Jimenez-Yuste, V.
    Perez, R.
    Batlle, J.
    Balda, I.
    Alperovich, G.
    Parra, R.
    HAEMOPHILIA, 2011, 17 (01) : 75 - 80
  • [5] Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy
    Castaman, Giancarlo
    Rocino, Angiola
    Mazzucconi, M. Gabriella
    Zanon, Ezio
    Gagliano, Fabio
    Molinari, Angelo C.
    BLOOD TRANSFUSION, 2015, 13 (04) : 631 - 638
  • [6] Considerations in individualizing prophylaxis in patients with haemophilia A
    Valentino, L. A.
    HAEMOPHILIA, 2014, 20 (05) : 607 - 615
  • [7] How much prophylaxis is enough in haemophilia?
    Carcao, Manuel
    Selvaratnam, Veena
    Blatny, Jan
    HAEMOPHILIA, 2024, 30 : 86 - 94
  • [8] Prophylaxis in the haemophilia population
    Blanchette, V. S.
    HAEMOPHILIA, 2010, 16 : 181 - 188
  • [9] A history of prophylaxis in haemophilia
    Moreno Moreno, Manuel
    Cuesta-Barriuso, Ruben
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (02) : 55 - 57
  • [10] Prophylaxis in adults with haemophilia
    Hay, C. R. M.
    HAEMOPHILIA, 2007, 13 : 10 - 15